Clinical Trial Update: A Study of the Efficacy and Safety of PerOx Quench on the Prevention of Oxaliplatin Treatment Induced Neuropathy [NA]

View source ↗

Summary

Clinical trial evaluating PerOx Quench to prevent oxaliplatin-induced neuropathy in colorectal and gastric cancer. The study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer

Drugs mentioned

• PerOx Quench (PerOx Quench)

Snippet

Sponsor: SMR Biotech Co., Ltd. | Conditions: Colorectal Cancer, Advanced Gastric Cancer | NA | Status: TERMINATED